The Journal of allergy and clinical immunology
-
J. Allergy Clin. Immunol. · Jun 2000
Randomized Controlled Trial Clinical TrialSalmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
Many patients with persistent asthma need both long-acting bronchodilators and inhaled corticosteroids for optimal asthma control. ⋯ Salmeterol 50 microg and fluticasone 100 microg combined in the Diskus powder delivery device offers significant clinical advantages over salmeterol or fluticasone alone at the same doses.